Aurobindo receives FDA approval for fingolimod capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application fingolimod capsules, 0.5mg.
Pharmacy
Events on anticompetitive practices feature community pharmacists’ perspectives
ALEXANDRIA, Va. – Congress may be stalling in its work to advance reforms of pharmacy benefit managers, but others in Washington are pressing on with their efforts – and they’re looking to independent pharmacy owners for their experiences and important perspectives.
SmithRx and Mark Cuban Cost Plus Drug Co. announce $9.5 million in client savings
SmithRx, a transparent and 100% pass-through PBM, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), announced this week that in 6 months, they have saved SmithRx clients more than $9.5 million in the autoimmune category alone.
Upcoming NCPA Items for pharmacy teams
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to announce these upcoming events for pharmacists and pharmacy team members: March 5 and 7 – CPESN Special Purpose Network webinars relating to long-term care.
HDA issues policy platform addressing drug shortages
The Healthcare Distribution Alliance (HDA) and its pharmaceutical distributor members today released a policy agenda to combat drug shortages.
PCMA releases statement on White House PBM Listening Session
The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Administration’s listening session on PBMs.
Failure to enact PBM reforms would be “wasted opportunity”
WASHINGTON, DC – The National Association of Chain Drug Stores, the National Community Pharmacists Association, FMI – The Food Industry Association, the National Grocers Association, the American Pharmacists Association, the National Association of Specialty Pharmacy, and the National Alliance of St
NACDS urges Biden to push for PBM reform
WASHINGTON – The National Association of Chain Drug Stores (NACDS) continues to call for the immediate implementation of reforms to address the tactics of pharmaceutical benefit middlemen, amid attempts by PBMs to stall Congressional action and perpetuate their harmful practices.
Camber launches generic Lipitor
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of atorvastatin calcium tablets, USP to its current portfolio. Click here to read product indications on DailyMed.com.
147 groups urge support of legislation to ensure access to essential Rx services for Medicare beneficiaries
WASHINGTON – The Future of Pharmacy Care Coalition announced today that more than 140 groups representing patients, rural and senior communities, pharmacists, health systems, and hospitals, delivered separate letters to Congressional leadership and the Biden Administration, including members of the
Cardinal Health annual research report examines milestone year in biosimilars
Cardinal Health released its 2024 Biosimilars Report: insights on a pivotal year of evolution and expansion, an analysis of key recent economic, competitive, legislative and societal developments in biosimilars.
Bob Azelby to join Cardinal Health board of directors
Cardinal Health announced today that its Board of Directors has elected Robert “Bob” Azelby as an independent director, effective March 1. Mr.
Rosacea Awareness Month to highlight importance of skin care in Rosacea treatment
CHICAGO – While rosacea sufferers enjoy a wider range of therapeutic options than ever before, without proper skin care they may not get the most out of treatment, dermatologists warn.
Signify Health launches heart arrhythmia testing
Signify Health, a CVS Health company announced the addition of a heart arrhythmia test to its Diagnostic and Preventive Services offering.
Local pharmacies on the brink, new poll reveals
ALEXANDRIA, Va. – As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association Tuesday released a survey showing many local pharmacies are running out of time.